LifeSignals Receives FDA 510 (k) Approval for LifeSignals LX1550 Multi-parameter Remote Monitoring Platform
Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.
News
LifeSignals LX1550 Platform Receives CE Mark
LifeSignals receives CE Mark Approval for LifeSignals LX1550E Multiparameter Remote Monitoring Platform. Enables healthtech partners to deliver continuous remote patient vital signs monitoring within hospital and home settings.
LifeSignals Wireless Medical Biosensor LP1250 Receives FDA Clearance
LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance
World’s first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings
LifeSignals Receives CE Mark Approval For LifeSignals ECG Remote Monitoring Biosensor Platform (LX1250E)
Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making
LifeSignals Accelerates Introduction Of Wireless Medical Biosensors For COVID-19 Remote Monitoring
LifeSignals accelerates introduction of single-use wireless medical biosensor patches for COVID-19 mass population remote monitoring
LifeSignals Receives HSA Clearance For Tripatch ECG Remote Monitoring Biosensor Platform In Singapore
LifeSignals receives HSA clearance for Tripatch™ ECG Remote Monitoring Biosensor Platform (LX1250) in Singapore
LifeSignals Inc Announces Merger Of LifeSignals Portfolio With The Connected Health Portfolio Of Renew Health Limited To Form LifeSignals Group Inc
LifeSignals Inc., a global leader in the field of wireless biosensor technology through the LifeSignals Processor silicon platform, announced its merger with the connected health assets of Renew Health Limited (Renew), based in Ireland and Singapore.
LifeSignals and ImagineMed Leverage The Cloud To Provide Industry’s First Wireless, Clinical-Grade, Health Data Monitoring At Home
LifeSignals, a pioneer in advanced biomonitoring, and ImagineMed, a provider of advanced telemedicine and remote health monitoring, announced today a partnership to bring clinical-grade, wireless monitoring to patients, enabling them to have the dual comfort of more freedom and more precise, real-time monitoring of their health metrics.
LifeSignals Announces FDA Clearance of Health Care Vital Sign Wireless Monitoring Biosensor and ECG Application
FDA Approval Paves Way for Next Generation of Remote Patient Diagnostics
LifeSignals Partners With INQCEL and Dreamtech To Enable Faster Time To Market, Lower Development Costs For New LSP-Based Wearables For Health, wellness, and safety
Collaboration provides comprehensive support for OEM development and manufacturing of new biosensor wearables and life-enhancing IoT nodes based on LifeSignals’ LSP.INQCEL provides expert design services and application-focused support tools for OEMs to develop LSP-based clinical- and consumer-grade wearables.
INQCEL provides expert design services and application-focused support tools for OEMs to develop LSP-based clinical- and consumer-grade wearables.Dreamtech provides LSP-centric industrial design and contract manufacturing services to take OEM product designs to high volume production in record times.
Dreamtech provides LSP-centric industrial design and contract manufacturing service to take OEM product designs to high volume production in record times.
